TI
XBI icon

Think Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Think Investments’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-360,000
Closed -$22.4M – 17
2015
Q3 		$22.4M Buy
+360,000
New +$28.4M 6.57% 7

Other funds holding XBI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Think Investments's XBI Position: Q4 2015 in Review

Think Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2015, closing a stake of 360,000 shares — an estimated $22.4M sold.

Think Investments first reported a position in XBI in Q3 2015 and held it in 1 quarter. The position peaked at $22.4M in Q3 2015. 199 funds tracked by Wall St. Rank hold XBI as of Q4 2015.

  • Think Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2015 after selling out during the quarter.
  • Think Investments sold 360,000 State Street SPDR S&P Biotech ETF shares in Q4 2015, an estimated $22.4M.
  • Think Investments first reported a position in State Street SPDR S&P Biotech ETF in Q3 2015 and held it in 1 quarter.
  • Think Investments's State Street SPDR S&P Biotech ETF position peaked at $22.4M in Q3 2015.
  • 199 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2015.

Based on Think Investments's 13F filing for Q4 2015, filed 16 Feb 2016.